Filed: 11/14/2024ACC: 0000950123-24-011804
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $269.41M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$269.41M
Total AUM (reported)
22.83M
Total Shares
Allocation by class
SHS$141.12M52.4%
COM NEW$82.71M30.7%
COM$33.05M12.3%
COM PAR $.01$12.53M4.7%
Portfolio Concentration
Top 3$226.75M84.2%
4–10$42.23M15.7%
11–25$434.0K0.2%
Top 3 weight
84.2%
Top 10 weight
99.8%
Voting Authority Distribution
Total shares with voting rights: 22.83M
Sole
Full voting authority
22.83M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
ROIVANT SCIENCES LTD
SOLEShares12.23M
TypeSH
Market value$141.12M
52.38%
Sole
12.23M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares7.18M
TypeSH
Market value$71.83M
26.66%
Sole
7.18M
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS, INC.
SOLEShares824.71K
TypeSH
Market value$13.81M
5.12%
Sole
824.71K
Shared
0.00
None
0.00
INSMED INC
SOLEShares171.70K
TypeSH
Market value$12.53M
4.65%
Sole
171.70K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS
SOLEShares1.36M
TypeSH
Market value$10.88M
4.04%
Sole
1.36M
Shared
0.00
None
0.00
NURIX THERAPEUTICS, INC.
SOLEShares325.79K
TypeSH
Market value$7.32M
2.72%
Sole
325.79K
Shared
0.00
None
0.00
PHARVARIS N.V.
SOLEShares242.34K
TypeSH
Market value$4.49M
1.67%
Sole
242.34K
Shared
0.00
None
0.00
INTELLIA THERAPEUTICS, INC.
SOLEShares128.57K
TypeSH
Market value$2.64M
0.98%
Sole
128.57K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS, INC.
SOLEShares90.57K
TypeSH
Market value$2.31M
0.86%
Sole
90.57K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares235.50K
TypeSH
Market value$2.05M
0.76%
Sole
235.50K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS, INC.
SOLEShares39.42K
TypeSH
Market value$434.0K
0.16%
Sole
39.42K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 12.23M | SH | $141.12M 52.38% | 12.23M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 7.18M | SH | $71.83M 26.66% | 7.18M | 0.00 | 0.00 |
CULLINAN THERAPEUTICS, INC.SOLE | COM | 824.71K | SH | $13.81M 5.12% | 824.71K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 171.70K | SH | $12.53M 4.65% | 171.70K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALSSOLE | COM NEW | 1.36M | SH | $10.88M 4.04% | 1.36M | 0.00 | 0.00 |
NURIX THERAPEUTICS, INC.SOLE | COM | 325.79K | SH | $7.32M 2.72% | 325.79K | 0.00 | 0.00 |
PHARVARIS N.V.SOLE | COM | 242.34K | SH | $4.49M 1.67% | 242.34K | 0.00 | 0.00 |
INTELLIA THERAPEUTICS, INC.SOLE | COM | 128.57K | SH | $2.64M 0.98% | 128.57K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS, INC.SOLE | COM | 90.57K | SH | $2.31M 0.86% | 90.57K | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COM | 235.50K | SH | $2.05M 0.76% | 235.50K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS, INC.SOLE | COM | 39.42K | SH | $434.0K 0.16% | 39.42K | 0.00 | 0.00 |